Ajanta Pharma Limited (AJANTPHARM) Stock Statistics & Valuation Metrics

Ajanta Pharma Limited has a market cap or net worth of ₹346.36B. The enterprise value is ₹335.69B.

Ajanta Pharma Limited has 124,912,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ajanta Pharma Limited’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 43.46%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Ajanta Pharma Limited had revenue of 46.48B and earned 9.20B in profits. Earnings per share was 73.56.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Ajanta Pharma Limited pays an annual dividend of ₹28, resulting in a dividend yield of 1.95%

Ajanta Pharma Limited upcoming earnings date is Jul 28, 2025, TBA (Confirmed).

Ajanta Pharma Limited as a current ratio of 2.85, with Debt / Equity ratio of 1.25%

In the past 12 months, Ajanta Pharma Limited has paid 2.69B in taxes.

Ajanta Pharma Limited EV to EBITDA ratio is 25.73, with an EV/FCF ratio of 38.88.

Ajanta Pharma Limited has ₹6.15B in cash and marketable securities with ₹474.20M in debt, giving a net cash position of -₹5.68B billion.

Gross margin is 70.13%, with operating margin of 48.70%, and net profit margin of 19.80%.

The average price target for Ajanta Pharma Limited is ₹3,140.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy